
In the current project, Nael Nadif Kasri aims to establish an all-human iPSC-based neuronal network platform to rigorously and multiparametrically assess the consequences of specific mutations in ASD risk genes on neuronal network function. The platform will be used to assess selected ASD gene variants of unknown significance and as a first-tier in vitro selection platform for testing genetic strategies for the amelioration of neuropathological phenotypes associated with genetically defined ASDs.


